Jaguar Gene Therapy

Risk score

57
Large logo of Jaguar Gene Therapy

Headquarters

Flag of United States of AmericaUnited States of America

Jaguar Gene Therapy is advancing progress in gene therapy for individuals afflicted by serious genetic conditions. Headed by the former AveXis leadership group and supported by Deerfield Management, a healthcare-focused investment company, Jaguar introduces efficient R&D, production, and clinical activities to expedite the advancement and potential authorization of treatments for severe genetic diseases. The organization’s current portfolio utilizes the established and well-defined AAV9 vector to ta